BioNTech aims to start producing mRNA vaccines in Rwanda in 2025

Vaccine manufacturer COVID-19 BioNTech aims to start production at its mRNA vaccine factory in Rwanda in 2025, according to company officials, which will thus become the first mRNA vaccine manufacturing site of a foreign company on the continent.

Share This Post: